These significant decreases in H-FABP and hs-cTnI levels over the course of the six-month rehabilitation and treatment post-CABG suggest a favorable evolution regarding the patients’ initial myocardial ischemia and necrosis. The gene discussed is TNNI3; the disease is myocardial ischemia.